3 ms·
Well, the fight is not over yet. Biogen has Aducanumab in phIII trials. Pretty big bet for them.
by shadowtree 8y ago
Well, the fight is not over yet.
Biogen has Aducanumab in phIII trials. Pretty big bet for them.
- shadowtree 8y agowell, and their results they just published are indeed encouraging. Nice bump on their stock.